Cargando…
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
SIMPLE SUMMARY: Over the past decade, cell-based immunotherapy has become a powerful strategy in solid cancer therapy. Tumor-infiltrating lymphocytes (TILs) are a group of intratumor lymphocytes. With the development of new technologies, the isolation and generation of TILs from tumor tissues have i...
Autores principales: | Zhao, Yueshui, Deng, Jian, Rao, Shuangfeng, Guo, Sipeng, Shen, Jing, Du, Fukuan, Wu, Xu, Chen, Yu, Li, Mingxing, Chen, Meijuan, Li, Xiaobing, Li, Wanping, Gu, Li, Sun, Yuhong, Zhang, Zhuo, Wen, Qinglian, Xiao, Zhangang, Li, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455018/ https://www.ncbi.nlm.nih.gov/pubmed/36077696 http://dx.doi.org/10.3390/cancers14174160 |
Ejemplares similares
-
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022) -
Dysregulation of B7 family and its association with tumor microenvironment in uveal melanoma
por: Chen, Yao, et al.
Publicado: (2022) -
Therapeutic prospects of ceRNAs in COVID-19
por: Liu, Lin, et al.
Publicado: (2022) -
Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review
por: Luo, Shuang, et al.
Publicado: (2022) -
The role of intestinal stem cell within gut homeostasis: Focusing on its interplay with gut microbiota and the regulating pathways
por: Luo, Haoming, et al.
Publicado: (2022)